Oviedo Medical Research

Oviedo, Florida 32765

1 studies enrolling now · 13 studies all time

What they study most

Atherosclerotic Cardiovascular Disease, Cardiovascular Disease, Diabetes Mellitus, Type 2, Diabetes, Type 2, High Cardiovascular Risk, Obesity, Obesity and Overweight, Osteoarthritis, Hip, Overweight, Overweight and/or Obesity, Pulmonary Disease, Chronic Obstructive, Type 2 Diabetes

Studies at this site

• A Study of LY3457263 Compared With Placebo in Participants With Type 2 Diabetes on a Stable Dose of Semaglutide or Tirzepatide — Recruiting now
• A Study to Learn About the Study Medicine (PF-08653944) in People With Obesity or Overweight and Type 2 Diabetes (T2D) — Running, not enrolling
• Efficacy and Safety of MET097 Once-Weekly in People With Overweight or Obesity — Running, not enrolling
• Study of Inclisiran to Prevent Cardiovascular (CV) Events in Participants With Established Cardiovascular Disease — Running, not enrolling
• A Study of LY3298176 (Tirzepatide) For the Maintenance of Body Weight Reduction in Participants Who Have Obesity or Overweight With Weight-Related Comorbidities — Completed
• A Study of Tirzepatide (LY3298176) in Participants With Obesity or Overweight — Completed
• Electrical Vestibular Nerve Stimulation (VeNS) Compared to Sham Control As a Means of Improving Glycemic Control in Adults with Type 2 Diabetes Mellitus — Completed
• Study to Evaluate the Efficacy and Safety of FX006 in Patients With Hip Osteoarthritis — Stopped early
• Assessment In a Real World Setting of the Effect of Inhaled Steroid-based Triple Therapy Versus the Combination of Tiotropium and Olodaterol on Reducing Chronic Obstructive Pulmonary Disease (COPD) Exacerbations [AIRWISE] — Completed
• Gan & Lee Insulin Glargine Target Type (2) Evaluating Research — Completed
• A Study of Tirzepatide (LY3298176) Versus Semaglutide Once Weekly as Add-on Therapy to Metformin in Participants With Type 2 Diabetes — Completed
• A Study of the Efficacy and Safety of Dulaglutide (LY2189265) in Participants With Type 2 Diabetes — Completed
• A Study to Evaluate the Effect of Long-term Treatment With BELVIQ (Lorcaserin HCl) on the Incidence of Major Adverse Cardiovascular Events and Conversion to Type 2 Diabetes Mellitus in Obese and Overweight Subjects With Cardiovascular Disease or Multiple Cardiovascular Risk Factors — Completed